Given the superior tumour targeting and low toxicity, HSA-MnO2-Ce6 NPs were then used for the PDT treatment of orthotopic bladder cancer (660 nm, 200 mW∙cm−2, 15 min). The gene discussed is ALB; the disease is urinary bladder carcinoma.